awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53701267-0AE6DC95-CD1F-45E4-AB98-81B0E8C5E70F
Q53701267-0AE6DC95-CD1F-45E4-AB98-81B0E8C5E70F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53701267-0AE6DC95-CD1F-45E4-AB98-81B0E8C5E70F
Acquired Resistance to Drugs Targeting Tyrosine Kinases.
P2860
Q53701267-0AE6DC95-CD1F-45E4-AB98-81B0E8C5E70F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53701267-0AE6DC95-CD1F-45E4-AB98-81B0E8C5E70F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31a0fe288867a49c0f0e1a8db3c4694ea1596528
P2860
Explaining why Gleevec is a specific and potent inhibitor of Abl kinase.